Here is why Moderna is better than Pfizer vaccine
Kathmandu. Two weeks after Pfizer claimed that their vaccine achieved an effectiveness of more than 90%, The American Biopharmaceutical company, Moderna on Monday announced that the preliminary data on its three-phased experimental study on its mRNA-1273 Coronavirus vaccine has indicated it to be 94.5 per cent effective.
Many reports claim that Moderna’s vaccine is better than Pfizer’s vaccine due to the following reasons:
Last week, when Moderna’s mRNA vaccine trial had reached the minimum threshold of 53 points, it had announced that it was busy accumulating and preparing the first analysis data to the Safety Monitoring Board.
Earlier in September, the company had enrolled 30,000 volunteers who were given two shots of the vaccine. The authorities were waiting for the patients to get ill so that they could collect data from them. At least 53 research participants needed to become ill with COVID-19 in order for the vaccine to be considered for authorization by the US Food and Drug Administration (FDA).
Moderna had released a 135-page blueprint document that revealed that the mRNA-1273 vaccine is the first of its kind which “instead of preventing infection, teaches the body to better fight the virus”, and hopefully will reduce its severity to that of a common cold.
Facebook Comment
Related News
latest Video
Trending News
- This Week
- This Month
